Skip to content
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Menu
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Menu
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Archives
LinKinVax has the trust of world-class partners and investors.
PRESS RELEASES
September 19, 2023
Vaccin thérapeutique : un premier patient traité pour un canceroropharyngé HPV-positif dans un essai à Gustave Roussy
CLICK HERE
PDF LINK
July 24, 2023
LinkinVAX completes first batch of ‘PanCov’ vaccine to prevent COVID-19
CLICK HERE
April 24, 2023
UNE PLATEFORME VACCINALE DE CLASSE MONDIALE
PDF LINK
April 11, 2023
Le Figaro – Vaccin contre le VIH : des résultats précoces encourageants en France
CLICK HERE
April 11, 2023
TF1 : Essais cliniques contre le VIH au journal de 13h
CLICK HERE
April 6, 2023
Laboratoires pharmaceutiques: l’arrivée des nouveaux vaccins bouleverse la hiérarchie mondiale
PDF LINK
March 14, 2023
Interview pour La Jaune et la Rouge – Mars 2023
CLICK HERE
February 7, 2023
Vaccin contre le VIH : pourquoi on échoue depuis 40 ans ? (science-et-vie.com)
CLICK HERE
VIEW MORE
press releases
LinKinVax and Gustave Roussy announced first patient dosedin Phase I/IIa clinical study on HPV.DCVax in HPV-positiveoropharyngeal cancer
Voir le communiqué
LinKinVax et Gustave Roussy annoncent un premier patienttraité dans l’essai clinique HPV.DCVax de phase I/IIa dans lecancer oropharyngé HPV-positif
Voir le communiqué
LinKinVax completes first batch production of “pancov”,its next generation multi-variant vaccine against covid and other coronaviruses
Voir le communiqué
VIEW MORE